Related Experiment Video
Updated: Jun 26, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation
Carla Olsnes1, Helen Stavang, Karl Brokstad
1Department of Surgical Sciences, Faculty of Medicine, University of Bergen, Bergen, Norway. carla.olsnes@ore.uib.no
Background:
OK-432, penicillin-killed Streptococcus pyogenes, is used in treating lymphangiomas and carcinomas. We have studied in vitro the role of mononuclear phagocytes (MNPs), including purified monocytes (MOs), in the immune response to OK-432. MIP-1alpha/beta and MCP-1 secretions were assessed in whole blood (WB), peripheral blood mononuclear cells (PBMCs) and purified MOs, after in vitro stimulation with OK-432 with or without adherence for 24 hours.
Results:
OK-432 stimulated MNPs to secrete MCP-1 and MIP-1alpha/beta in healthy individuals and in head and neck squamous cell carcinoma (HNSCC) patients, except for OK-432 stimulation of WB giving a minimal MIP-1alpha/beta response. Upon culture on low-attachment wells, a spontaneous chemokine secretion was observed, with an unchanged secretion following OK-432 stimulation. Inhibition of Syk kinase and/or PI-3 kinase did not significantly change the chemokine response to OK-432, except for MIP-1alpha production being increased upon Syk inhibitor addition and an increased MCP-1 response upon addition of both inhibitors. Adhesion may possibly involve beta1 and/or beta3 integrins, not beta2, whereas beta(1-3) integrins may act as co-stimulatory receptors for OK-432. Based on direct blockage of CD36 or CD18 by antibodies, MCP-1 production may be mediated by CD18 while MIP-1beta and MCP-1 production may occur upon binding to CD36.
Conclusion:
Adherent human MOs produce MCP-1 and MIP-1alpha/beta upon stimulation with OK-432. CD36 modulates MIP-1beta and MCP-1 response. Thus, to some extent OK-432 acts as a substance whereby only MOs adhered to surfaces secrete MCP-1 and MIP-1alpha/beta, in part explaining why OK-432 is suited as a biological response modifying drug.
Insights
OK-432 stimulates adherent monocytes (MOs) to release immune-signaling chemokines like MCP-1 and MIP-1alpha/beta. This interaction, partly mediated by CD36, explains OK-432
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- OK-432, derived from Streptococcus pyogenes, is clinically used for lymphangiomas and carcinomas.
- Mononuclear phagocytes (MNPs), including monocytes (MOs), play a role in immune responses.
- Understanding MNP interaction with OK-432 is crucial for its therapeutic application.
Purpose of the Study:
- To investigate the in vitro immune response of MNPs to OK-432.
- To assess the secretion of chemokines (MIP-1alpha/beta, MCP-1) by MOs upon OK-432 stimulation.
- To elucidate the mechanisms of MNP activation by OK-432, including adherence and specific receptors.
Main Methods:
- In vitro stimulation of whole blood (WB), PBMCs, and purified MOs with OK-432.
- Assessment of MIP-1alpha/beta and MCP-1 chemokine secretion.
- Evaluation of the role of adherence, Syk kinase, PI-3 kinase, and integrins (beta1, beta3, beta2) in the response.
- Investigation of CD36 and CD18 involvement via antibody blockage.
Main Results:
- OK-432 induced MCP-1 and MIP-1alpha/beta secretion from MNPs in healthy individuals and HNSCC patients.
- Minimal MIP-1alpha/beta response was observed upon OK-432 stimulation of whole blood.
- Adherent MOs showed increased chemokine secretion upon OK-432 stimulation, partly mediated by CD36 and CD18.
- Syk and PI-3 kinase inhibition showed varied effects on chemokine production.
Conclusions:
- Adherent human MOs are key producers of MCP-1 and MIP-1alpha/beta in response to OK-432.
- The CD36 receptor plays a role in modulating MIP-1beta and MCP-1 secretion.
- OK-432's ability to elicit chemokine release primarily from adhered MOs contributes to its efficacy as a biological response modifying drug.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Streptococcal Pharyngitis
The JAK-STAT Signaling Pathway
Regulation of Hematopoietic Stem Cells

